Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · IEX Real-Time Price · USD
0.351
-0.035 (-8.96%)
At close: May 17, 2024, 3:59 PM
0.233
-0.119 (-33.78%)
After-hours: May 17, 2024, 7:59 PM EDT
Virios Therapeutics Market Cap
Virios Therapeutics has a market cap or net worth of $7.13 million as of May 17, 2024. Its market cap has decreased by -63.65% in one year.
Market Cap
7.13M
Enterprise Value
4.75M
1-Year Change
-63.65%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since the IPO on December 17, 2020, Virios Therapeutics's market cap has decreased from $78.32M to $7.13M, a decrease of -90.90%. That is a compound annual growth rate of -50.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 6.80M | -8.11% |
May 16, 2024 | 7.40M | -5.13% |
May 15, 2024 | 7.80M | 5.41% |
May 14, 2024 | 7.40M | 8.82% |
May 13, 2024 | 6.80M | - |
May 10, 2024 | 6.80M | -5.56% |
May 9, 2024 | 7.20M | -13.25% |
May 8, 2024 | 8.30M | 3.75% |
May 7, 2024 | 8.00M | 1.27% |
May 6, 2024 | 7.90M | - |
May 3, 2024 | 7.90M | -2.47% |
May 2, 2024 | 8.10M | -4.71% |
May 1, 2024 | 8.50M | -2.30% |
Apr 30, 2024 | 8.70M | -4.40% |
Apr 29, 2024 | 9.10M | 1.11% |
Apr 26, 2024 | 9.00M | 2.27% |
Apr 25, 2024 | 8.80M | 7.32% |
Apr 24, 2024 | 8.20M | -1.20% |
Apr 23, 2024 | 8.30M | 1.22% |
Apr 22, 2024 | 8.20M | -2.38% |
Apr 19, 2024 | 8.40M | -3.45% |
Apr 18, 2024 | 8.70M | - |
Apr 17, 2024 | 8.70M | - |
Apr 16, 2024 | 8.70M | -4.40% |
Apr 15, 2024 | 9.10M | -8.08% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NeuroMetrix | 8.14M |
TRxADE HEALTH | 7.93M |
China Jo-Jo Drugstores | 7.81M |
Vaccinex | 7.79M |
NuCana | 7.77M |
Trevena | 7.65M |
Heart Test Laboratories | 7.60M |
ASLAN Pharmaceuticals | 7.51M |